Bridgeway Capital Management’s BiomX PHGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-261
Closed -$13.9K 1361
2023
Q4
$13.9K Hold
261
﹤0.01% 1345
2023
Q3
$17.4K Hold
261
﹤0.01% 1345
2023
Q2
$17.8K Hold
261
﹤0.01% 1364
2023
Q1
$15.1K Hold
261
﹤0.01% 1365
2022
Q4
$9.24K Sell
261
-48
-16% -$2.65K ﹤0.01% 1359
2022
Q3
$20K Hold
309
﹤0.01% 1391
2022
Q2
$43K Hold
309
﹤0.01% 1290
2022
Q1
$113K Sell
309
-210
-40% -$62.5K ﹤0.01% 1248
2021
Q4
$158K Sell
519
-537
-51% -$215K ﹤0.01% 1181
2021
Q3
$614K Buy
1,056
+509
+93% +$394K 0.01% 976
2021
Q2
$568K Sell
547
-100
-15% -$116K 0.01% 1026
2021
Q1
$876K Buy
+647
New +$875K 0.02% 908

Other funds holding PHGE

Bridgeway Capital Management's PHGE Position: Q1 2024 in Review

Bridgeway Capital Management sold out of BiomX (PHGE) in Q1 2024, closing a stake of 261 shares — an estimated $13.9K sold.

Bridgeway Capital Management first reported a position in PHGE in Q1 2021 and held it in 12 quarters. The position peaked at $876K in Q1 2021. 9 funds tracked by Wall St. Rank hold PHGE as of Q1 2024.

  • Bridgeway Capital Management reported no remaining BiomX position as of Q1 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 261 BiomX shares in Q1 2024, an estimated $13.9K.
  • Bridgeway Capital Management first reported a position in BiomX in Q1 2021 and held it in 12 quarters.
  • Bridgeway Capital Management's BiomX position peaked at $876K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held BiomX as of Q1 2024.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.